Annual Retained Earnings
-$85.44 M
-$4.79 M-5.94%
July 31, 2024
Summary
- As of February 26, 2025, BCTX annual retained earnings is -$85.44 million, with the most recent change of -$4.79 million (-5.94%) on July 31, 2024.
- During the last 3 years, BCTX annual retained earnings has fallen by -$56.30 million (-193.20%).
- BCTX annual retained earnings is now -7767509.09% below its all-time high of -$1100.00, reached on July 31, 2014.
Performance
BCTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$91.25 M
-$5.80 M-6.79%
October 31, 2024
Summary
- As of February 26, 2025, BCTX quarterly retained earnings is -$91.25 million, with the most recent change of -$5.80 million (-6.79%) on October 31, 2024.
- Over the past year, BCTX quarterly retained earnings has stayed the same.
- BCTX quarterly retained earnings is now -8294981.82% below its all-time high of -$1100.00, reached on July 31, 2014.
Performance
BCTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
BCTX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.9% | 0.0% |
| 3 y3 years | -193.2% | 0.0% |
| 5 y5 years | -479.4% | 0.0% |
BCTX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -193.2% | at low | -300.9% | at low |
| 5 y | 5-year | -479.4% | at low | -551.4% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
BriaCell Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | -$91.25 M(+6.8%) |
| Jul 2024 | -$85.44 M(+5.9%) | -$85.44 M(+1.4%) |
| Apr 2024 | - | -$84.23 M(-2.0%) |
| Jan 2024 | - | -$85.95 M(+15.1%) |
| Oct 2023 | - | -$74.65 M(-7.4%) |
| Jul 2023 | -$80.65 M(+33.6%) | -$80.65 M(+3.1%) |
| Apr 2023 | - | -$78.23 M(+6.7%) |
| Jan 2023 | - | -$73.34 M(+19.3%) |
| Oct 2022 | - | -$61.46 M(+1.8%) |
| Jul 2022 | -$60.35 M(+107.1%) | -$60.35 M(+118.8%) |
| Apr 2022 | - | -$27.58 M(+21.2%) |
| Jan 2022 | - | -$22.76 M(+25.5%) |
| Oct 2021 | - | -$18.14 M(-37.8%) |
| Jul 2021 | -$29.14 M(+60.4%) | -$29.14 M(+108.1%) |
| Apr 2021 | - | -$14.01 M(-22.6%) |
| Jan 2021 | - | -$18.11 M(+5.7%) |
| Oct 2020 | - | -$17.12 M(-5.8%) |
| Jul 2020 | -$18.17 M(+23.2%) | -$18.17 M(+16.6%) |
| Apr 2020 | - | -$15.59 M(-1.8%) |
| Jan 2020 | - | -$15.88 M(+8.7%) |
| Oct 2019 | - | -$14.60 M(-1.0%) |
| Jul 2019 | -$14.75 M(+51.4%) | -$14.75 M(+18.9%) |
| Apr 2019 | - | -$12.41 M(+7.1%) |
| Jan 2019 | - | -$11.58 M(+10.7%) |
| Oct 2018 | - | -$10.46 M(+7.4%) |
| Jul 2018 | -$9.74 M(+45.7%) | -$9.74 M(+7.9%) |
| Apr 2018 | - | -$9.03 M(+12.0%) |
| Jan 2018 | - | -$8.06 M(+15.3%) |
| Oct 2017 | - | -$6.99 M(+4.6%) |
| Jul 2017 | -$6.68 M(+56.4%) | -$6.68 M(+21.5%) |
| Apr 2017 | - | -$5.50 M(+13.8%) |
| Jan 2017 | - | -$4.83 M(+9.5%) |
| Oct 2016 | - | -$4.41 M(+3.2%) |
| Jul 2016 | -$4.27 M(+60.0%) | -$4.27 M(+3.6%) |
| Apr 2016 | - | -$4.12 M(+18.3%) |
| Jan 2016 | - | -$3.49 M(+17.6%) |
| Oct 2015 | - | -$2.97 M(+11.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2015 | -$2.67 M(>+9900.0%) | -$2.67 M(+3.5%) |
| Apr 2015 | - | -$2.58 M(+23.8%) |
| Jan 2015 | - | -$2.08 M(-81.2%) |
| Oct 2014 | - | -$11.10 M(>+9900.0%) |
| Jul 2014 | -$1100.00(-100.0%) | -$1100.00(-100.0%) |
| Apr 2014 | - | -$4.01 M(+17.7%) |
| Jan 2014 | - | -$3.40 M(-5.7%) |
| Oct 2013 | - | -$3.61 M(+2.6%) |
| Jul 2013 | -$3.52 M(+4.5%) | -$3.52 M(+1.1%) |
| Apr 2013 | - | -$3.48 M(+2.3%) |
| Jan 2013 | - | -$3.40 M(-1.5%) |
| Oct 2012 | - | -$3.45 M(+2.5%) |
| Jul 2012 | -$3.37 M(+33.0%) | -$3.37 M(+12.8%) |
| Apr 2012 | - | -$2.98 M(+16.8%) |
| Jan 2012 | - | -$2.55 M(-1.3%) |
| Oct 2011 | - | -$2.59 M(+2.2%) |
| Jul 2011 | -$2.53 M(+84.8%) | -$2.53 M(+24.3%) |
| Apr 2011 | - | -$2.04 M(+20.0%) |
| Jan 2011 | - | -$1.70 M(+13.9%) |
| Oct 2010 | - | -$1.49 M(+8.8%) |
| Jul 2010 | -$1.37 M(+206.1%) | -$1.37 M(+29.0%) |
| Apr 2010 | - | -$1.06 M(+139.8%) |
| Jan 2010 | - | -$442.50 K(-11.9%) |
| Oct 2009 | - | -$502.20 K(+12.3%) |
| Jul 2009 | -$447.20 K(+95.0%) | -$447.20 K(+55.0%) |
| Apr 2009 | - | -$288.50 K(+6.6%) |
| Jan 2009 | - | -$270.70 K(+10.9%) |
| Oct 2008 | - | -$244.00 K(+6.4%) |
| Jul 2008 | -$229.30 K(+82.7%) | -$229.30 K(+29.3%) |
| Apr 2008 | - | -$177.40 K(+15.3%) |
| Jan 2008 | - | -$153.90 K(+6.3%) |
| Oct 2007 | - | -$144.80 K(+15.4%) |
| Jul 2007 | -$125.50 K(+1359.3%) | -$125.50 K(+39.9%) |
| Apr 2007 | - | -$89.70 K(+18.3%) |
| Jan 2007 | - | -$75.80 K(+103.8%) |
| Oct 2006 | - | -$37.20 K |
| Jul 2006 | -$8600.00 | - |
FAQ
- What is BriaCell Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for BriaCell Therapeutics?
- What is BriaCell Therapeutics annual retained earnings year-on-year change?
- What is BriaCell Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for BriaCell Therapeutics?
- What is BriaCell Therapeutics quarterly retained earnings year-on-year change?
What is BriaCell Therapeutics annual retained earnings?
The current annual retained earnings of BCTX is -$85.44 M
What is the all time high annual retained earnings for BriaCell Therapeutics?
BriaCell Therapeutics all-time high annual retained earnings is -$1100.00
What is BriaCell Therapeutics annual retained earnings year-on-year change?
Over the past year, BCTX annual retained earnings has changed by -$4.79 M (-5.94%)
What is BriaCell Therapeutics quarterly retained earnings?
The current quarterly retained earnings of BCTX is -$91.25 M
What is the all time high quarterly retained earnings for BriaCell Therapeutics?
BriaCell Therapeutics all-time high quarterly retained earnings is -$1100.00
What is BriaCell Therapeutics quarterly retained earnings year-on-year change?
Over the past year, BCTX quarterly retained earnings has changed by $0.00 (0.00%)